Pete is the founder and the CEO of MedTate. He heads the executive management of the MedCare division, and oversees the manufacturing and operational activities of the company.
Pete has consistently excelled in his academics as well as extracurricular activities. Throughout his academic career, he has studied on scholarships, whilst consistently being in the top 1 percentile of the class. He is a gold medallist at the Maths Olympiad. He has also won several awards including the prestigious Graduate Merit Award at London School Economics.
Pete studied his Bachelor of Engineering with Joint Honours in Business Management from the King’s College London. He then went on to complete his Master of Science degree from London School of Economics as a scholarship student. Further, he worked in several institutions in the financial services industry including HSBC, Deloitte and Fidelity National Information Services (Previously SunGard).
Despite a secure career trajectory, his increasing passion on the nature’s ability to care and cure made him change his career direction towards healthcare industry. He decided to further embark on a PhD program to learn the financial aspects of setting up and managing a healthcare company. Thus he founded MedTate with the belief to use the best that Mother Nature offers, to develop breakthrough healthcare products. With the mission of Curing with Care.
Today, MedTate has developed several healthcare products. Its flagship product Ojamin is now available at the top 150 UK stores, including Selfridges and John Bell & Croydon. Further, the company launched its biotech division MedCure™, which has potential blockbuster products in the pipeline. It has formed several R&D and business collaborations with top academic institutions and reputed corporations.
Prof. Ebrahim is the Executive Director at MedTate. Professor Naderali completed his studies in Pharmacology from the University of Sunderland followed by a scholarship from the University of Edinburgh where he completed his post-graduate PhD study in Pharmacology. After a few years of successful post-doctoral and research lectureship posts, he went on to train as a medical doctor.
After completion of his medical training, Ebrahim worked as a medical doctor in NHS whilst continuing his academic and research interests in obesity, diabetes and cardiovascular disease. This resulted in him obtaining the Chair of Obesity and Metabolic Disease in 2009 from the Liverpool Hope University. Moreover Prof. Naderali successfully obtained the Fellowship of Royal College of Physicians Edinburgh in 2013.
Professor Naderali has been collaborating with pharmaceutical industry for over 25 years and for the past 10 years he has held many senior roles (Medical Director, Global Medical Director and Global Chief Medical Director) in major pharmaceutical companies such as Pfizer, Eli-Lilly and Walgreens Boots Alliance (WBA). As a global Medical Director, Ebrahim has led successful launch of six block buster drugs in diabetes.
Professor Naderali continued with his academics and research throughout his leadership roles within the pharmaceutical industry, resulting in over 100 publications and presenting at over 200 national and international scientific conferences, as well as reviewing and editing manuscripts for over 20 scientific journals. Professor Naderali has led the NHS North West Ethic Committee for several years and currently is one of the Medical appraisals of the Faculty of Pharmaceutical Medicine.
Professor Angell is the Chairman of the Advisory Board at MedTate. Professor Angell has been one of the first advocates of MedTate’s flagship product Ojamin, and is now a champion of our nutraceutical range. He is presently the Emeritus Professor at the London School of Economics and Political Science having previously being the Professor at Department of Management, LSE.
Professor Angell has a first degree in Pure Mathematics, and a doctorate in Algebraic Number Theory. He first came to prominence through his work in computer graphics. Apart from his academic achievements, he has also written software and produced animation sequences for television advertisements, as well as for the television programs on science and business.
Professor Angell has previously acted as a strategic advisor on the management, security and strategic impact of information systems to many national and international organizations, governments and the EU. Until 2000 he was a personal advisor to the Cabinet of the Director General of UNESCO (Federico Mayor). He has previously worked with the Malaysian Prime Minister, Dr. Mahathir Mohamad and the (now ex) Deputy Prime Minister, Anwar Ibrahim, and His Highness Sheikh Mohammed Al Maktoum, Crown Prince of Dubai.
Abigail Stuart-Menteth is the Non-Executive director of Public Relations and Communications at MedTate. Abigail has worked in communications for over 30 years, with experience across high profile cultural and corporate campaigns, including the inaugural exhibition at the launch of Damien Hirst’s Newport Street Gallery and the launch and IPO of Chinese media distribution company PCG Entertainment plc.
Abigail has experience across CSR, luxury, fashion, culture and arts PR, B2B PR, IPOs and significant experience working across the international NGO community. She has worked on campaigns for and with a wealth of names from Greenpeace International, Amnesty International, the International Red Cross, the World Business Council for Sustainable Development, RMC, Siemens, BMW, from UN agencies UNEP and ILO through to MTV. Her luxury and lifestyle campaigns include running campaigns for Johnstons of Elgin, the Household Cavalry Foundation, Nicky Clarke and more.
Abigail is a Fellow of the Royal Society of Arts (RSA) and a Member of the Institute of Public Relations. She won a PR Week award for her work with WWF on their international forests campaign.
Rishi Solan has been a Non-Executive Director at MedTate since September 2019, advising on legal, commercial and regulatory affairs. He has a wealth of expertise, particularly in various sectors of the life sciences industry, including pharmaceuticals, medical devices and biotechnology.
Rishi is a corporate finance lawyer by profession with significant experience advising both private and publicly listed companies, as well as start-ups and entrepreneurs, on a broad range of corporate, commercial and regulatory matters, including mergers and acquisitions, joint ventures, IPOs, equity and debt capital markets transactions and all aspects of corporate governance. He has spent over a decade working at some of the leading law firms in the City of London and internationally. He currently practises in the London office of DAC Beachcroft LLP.
Rishi holds a Bachelor of Arts degree from Boston University (USA), Master of Laws degree from the University of Warwick (England) and is an English qualified lawyer.